Drug intelligence / Profile preview

Extracellular vesicles derived from human induced neural stem cell

Development stage
Unknown
Lead developer
Texas A&M College of Medicine
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intranasal
01

Overview

Extracellular vesicles derived from human induced neural stem cells (hiPSC-NSC-EVs or NSC-EVs) are nano-sized biologic particles secreted by neural stem cells generated from human induced pluripotent stem cells. These EVs contain a cargo of microRNAs and proteins that can be transferred to recipient brain cells such as neurons, microglia, and astrocytes. The mechanism of action is primarily anti-inflammatory and neuroprotective; the EVs modulate neuroinflammation by delivering their molecular constituents into target brain cells in a paracrine fashion. Preclinical studies have shown that intranasal administration of these EVs leads to their incorporation into various brain regions and results in reduced activation of microglia and astrocytes, enhanced hippocampal neurogenesis, preservation of motor function after stroke or injury, and attenuation of neuropathological changes associated with Alzheimer's disease. This therapy is being developed as a non-cellular alternative to direct NSC transplantation for treating neurodegenerative diseases such as Alzheimer's disease and stroke[1][2][3][5][6].

Other names
human induced pluripotent stem cell-derived neural stem cell extracellular vesicleshuman neural stem cell-derived extracellular vesicles

Beyond the preview

Go deeper on Extracellular vesicles derived from human induced neural stem cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular vesicles derived from human induced neural stem cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call